Who Owns VYNE?

VYNE Therapeutics Inc. — Institutional Ownership & 13F Holdings

$0.64

+0.00 (+0.60%)

Market Cap

$9.8M

Shares Outstanding

16,664,900

Institutional Holders

37

Total Inst. Value

$9.7M

% of Float Held

52.2%

QoQ Holder Change

+11

Institutional data as of Q1 2025

New Positions

9

Closed Positions

5

Increased

14

Decreased

7

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1EVENTIDE ASSET MANAGEMENT, LLC$2.4M1,394,336
2ACORN CAPITAL ADVISORS, LLC$1.2M785,938
3DAFNA Capital Management LLCNew$1.0M636,103
4VANGUARD GROUP INC$750K475,650
5Exome Asset Management LLC$731K462,801
6Palo Alto Investors LP$704K445,434
7ADAGE CAPITAL PARTNERS GP, L.L.C.$544K344,134
8Patient Square Capital LPNew$406K257,033
9Parkman Healthcare Partners LLC$344K217,978
10PRELUDE CAPITAL MANAGEMENT, LLC$224K141,502

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold VYNE?

As of Q1 2025, 37 institutional investors report holding VYNE (VYNE Therapeutics Inc.) in their 13F filings.

What percentage of VYNE Therapeutics Inc. is owned by institutions?

Institutional investors hold approximately 52.2% of VYNE Therapeutics Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most VYNE?

The largest institutional holder of VYNE is EVENTIDE ASSET MANAGEMENT, LLC with $2.4M in shares.

Are institutions buying or selling VYNE?

This quarter, 9 institutions opened new positions in VYNE and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.